Effect of wet-cupping in treatment oligomenorrhea

Phase 3

• Conditions: Polycystic Ovarian Syndrom.; Polycystic Ovarian Syndrom; E28.0

• Registration Number: IRCT20210809052118N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 92

Inclusion Criteria

Women with polycystic ovarian- age between 18 and 35 with menstrual disorder-who have menstrual cycles of at least 60 days in the last year.

Exclusion Criteria

Patients using metformin or every hormonal drugs, including herbal and phytoestrogens, in the last three months
Positive BHCG titer or lactating women
People with coagulation disorders and anemia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of menstrual cycle. Timepoint: First day and weeks 2, 4, 6, 8, 10, 12. Method of measurement: Asking the patient.

Secondary Outcome Measures

Name	Time	Method
ength of bleeding period. Timepoint: The first day and weeks 2? 4? 6? 8?10?12. Method of measurement: Ask the patient based on the number of days of bleeding.;The amount of excess hair(hirsutism). Timepoint: The first day and weeks 4? 8? 12. Method of measurement: the Freeman Galloway chart.;Quality of life of patients with polycystic ovary syndrome. Timepoint: The first day and weeks 4? 8? 12. Method of measurement: PCOSQ-50 Questionnaire.